Abstract
There is increasing evidence for myocarditis as a complication of the mRNA coronavirus disease 2019 (COVID-19) vaccination. We report the case of a 20-year-old previously healthy man who presented with fever and chest pain 2 days after the second dose of mRNA-1273 vaccine. Electrocardiogram and laboratory studies showed extensive ST-segment elevation accompanied by elevated cardiac biomarkers. Cardiac magnetic resonance (CMR) revealed late gadolinium enhancement (LGE) characteristics of myocarditis. The patient rapidly improved with conservative management and was discharged on hospital day 6. As an advantage over previous reports, we performed a 1-month follow-up CMR. It showed improvement in myocardial edema but persistence of LGE which may indicate irreversible fibrosis. CMR may be useful not only for diagnosis but also for prognostic evaluation of myocarditis after COVID-19 mRNA vaccination.
【저자키워드】 mRNA vaccination, Coronavirus disease 2019, Acute myocarditis, 【초록키워드】 COVID-19, coronavirus disease, vaccination, Biomarkers, magnetic resonance imaging, hospital, Diagnosis, fibrosis, Laboratory, electrocardiogram, Characteristics, COVID-19 vaccination, persistence, myocarditis, mRNA, Fever, Patient, edema, Follow-up, persistent, prognostic, Evidence, cardiac, chest pain, COVID-19 mRNA Vaccination, Conservative management, mRNA-1273 vaccine, second dose, poor prognosis, vaccine administration, Myocardial, performed, healthy, reported, elevated, discharged, accompanied, 【제목키워드】 COVID-19 vaccination, myocarditis, mRNA, cardiac,